by synergycap1 | Sep 7, 2017 | Accidents and Safety, Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Epinephrine (Drug), Finance, Food and Drug Administration, Medical Devices, Mylan Inc, Non-Bank Loans, Pfizer Inc, Working Capital
The agency said Pfizer ignored hundreds of complaints that the device failed to operate in life-threatening emergencies, including incidents when patients died
by synergycap1 | Aug 28, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Food and Drug Administration, Non-Bank Loans, Regulation and Deregulation of Industry, Stem Cells, Working Capital
The agency reported actions against a biotech company and two large stem cell clinics over unapproved treatments, a move it said was necessary to make way for speedier approval of legitimate therapies.
by synergycap1 | Aug 3, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Clinical Trials, Drugs (Pharmaceuticals), Economics, Finance, Food and Drug Administration, Generic Brands and Products, Law and Legislation, Non-Bank Loans, United States Politics and Government, Working Capital
The Senate capped a difficult seven months on Thursday by approving financing for the F.D.A. and expanding access to experimental treatments for people with terminal illnesses.
by synergycap1 | Jul 28, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, E-Cigarettes, Economics, Finance, Food and Drug Administration, Nicotine, Non-Bank Loans, Regulation and Deregulation of Industry, Smoking and Tobacco, Working Capital
By SHEILA KAPLAN July 28, 2017 Electronic-cigarette makers won a major reprieve on Friday when the Food and Drug Administration delayed regulations that could have removed many of their products from the market and opened the door to endorsing e-cigarettes...
